Table 1 Baseline characteristics of the 20 participants included in the pilot study
Baseline characteristics | Usual care group (n = 11) | Intervention group (n = 9) | |
|---|---|---|---|
Gender, n (%) | Male | 4 (36) | 2 (22) |
Age, years, mean ± SD |  | 59 ± 14 | 63 ± 10 |
MUST score, n (%) | 0 | 9 (82) | 7 (78) |
| Â | 1 | 1 (9) | 0 (0) |
|  | ≥2 | 1 (9) | 2 (22) |
Primary tumour, n (%) | Gastrointestinal | 5 (46) | 3 (33) |
| Â | Breast cancer | 2 (18) | 2 (22) |
| Â | Gynecological | 4 (36) | 4 (44) |
Metastases, n (%) | Yes | 7 (64) | 5 (56) |
| Â | No | 4 (36) | 4 (44) |
Emetogenicity chemotherapy, n (%) | High | 1 (9) | 0 (0) |
| Â | Moderate | 5 (46) | 7 (78) |
| Â | Low | 5 (46) | 2 (22) |
Chemotherapy schedule, n (%) | Two weekly | 1 (9) | 0 (0) |
| Â | Three weekly | 10 (91) | 9 (100) |
Comorbidities, n (%) | None | 5 (46) | 3 (33) |
| Â | Diabetes | 2 (18) | 0 (0) |
| Â | Hypertension | 2 (18) | 1 (11) |
| Â | Cardiovascular | 1 (9) | 0 (0) |
| Â | Other | 4 (36) | 2 (22) |